Acerta Pharma has the responsibility of developing both internally discovered compounds as well as AstraZeneca sourced compounds for hematological malignancies. The company began operations in 2013 with the vision of combining cutting edge science, unique covalent technology, and an experienced, dedicated team in order to deliver novel targeted therapies for patients with cancer.
Acerta Pharma Address
Molenstraat 110. Oss, 5342 CC. Netherlands OSS, null
Acerta Pharma Email
Past Companies
Acerta Pharma B.V.Associate Director, Medical Safety
InterMune, Inc. (A wholly owned subsidiary of Roche)Senior Manager, Drug Safety Risk Management